DMRA
Price
$22.05Alerts
Change
-$1.20 (-5.16%)
Updated
Nov 12 closing price
Capitalization
1.46B
132 days until earnings call
Intraday BUY SELL Signals
INBX
Price
$87.75Alerts
Change
-$2.84 (-3.14%)
Updated
Nov 12 closing price
Capitalization
1.24B
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

DMRA vs INBX

DMRA vs INBX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DMRA vs. INBX commentary
Nov 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMRA is a Hold and INBX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DMRA with price predictions
Nov 12, 2026

DMRA's RSI Indicator ascending out of oversold territory

The RSI Oscillator for DMRA moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 25 of the 27 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on DMRA as a result. In 77 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

The 10-day moving average for DMRA crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where DMRA advanced for three days, in 206 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 48 cases where DMRA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

DMRA moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for DMRA moved below the 200-day moving average on October 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DMRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

DMRA broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for DMRA entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.790) is normal, around the industry mean (3.498). DMRA has a moderately low P/E Ratio (-91.154) as compared to the industry average of (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. DMRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for INBX with price predictions
Nov 12, 2026

INBX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for INBX turned positive on November 06, 2026. Looking at past instances where INBX's MACD turned positive, the stock continued to rise in 33 of 36 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INBX's RSI Oscillator exited the oversold zone, 30 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Momentum Indicator moved above the 0 level on November 11, 2026. You may want to consider a long position or call options on INBX as a result. In 68 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

Following a +14.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where INBX advanced for three days, in 224 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

INBX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INBX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for INBX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-23.481) is normal, around the industry mean (3.498). P/E Ratio (-9.518) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (1250.000) is also within normal values, averaging (440.869).

The Tickeron Seasonality Score of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. INBX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
DMRA vs INBX: Fundamental Ratings
DMRA
INBX
OUTLOOK RATING
1..100
279
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
3857
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5658
P/E GROWTH RATING
1..100
1545
SEASONALITY SCORE
1..100
n/a42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DMRA's Valuation (2) in the null industry is in the same range as INBX (7). This means that DMRA’s stock grew similarly to INBX’s over the last 12 months.

DMRA's Profit vs Risk Rating (38) in the null industry is in the same range as INBX (57). This means that DMRA’s stock grew similarly to INBX’s over the last 12 months.

DMRA's SMR Rating (99) in the null industry is in the same range as INBX (100). This means that DMRA’s stock grew similarly to INBX’s over the last 12 months.

DMRA's Price Growth Rating (56) in the null industry is in the same range as INBX (58). This means that DMRA’s stock grew similarly to INBX’s over the last 12 months.

DMRA's P/E Growth Rating (15) in the null industry is in the same range as INBX (45). This means that DMRA’s stock grew similarly to INBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DMRAINBX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
74%
COMPARISON
Comparison
Nov 13, 2026
Stock price -- (DMRA: $22.05 vs. INBX: $87.75)
Brand notoriety: DMRA and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMRA: 102% vs. INBX: 65%
Market capitalization -- DMRA: $1.46B vs. INBX: $1.24B
DMRA [@Biotechnology] is valued at $1.46B. INBX’s [@Biotechnology] market capitalization is $1.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMRA’s FA Score shows that 2 FA rating(s) are green while INBX’s FA Score has 1 green FA rating(s).

  • DMRA’s FA Score: 2 green, 3 red.
  • INBX’s FA Score: 1 green, 4 red.
According to our system of comparison, DMRA is a better buy in the long-term than INBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMRA’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 5 bullish TA indicator(s).

  • DMRA’s TA Score: 4 bullish, 6 bearish.
  • INBX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INBX is a better buy in the short-term than DMRA.

Price Growth

DMRA (@Biotechnology) experienced а +0.87% price change this week, while INBX (@Biotechnology) price change was +9.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.04%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -16.99%.

Reported Earning Dates

DMRA is expected to report earnings on Mar 25, 2027.

INBX is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (+2.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

DMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMRA has been closely correlated with COGT. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if DMRA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMRA
1D Price
Change %
DMRA100%
-5.16%
COGT - DMRA
76%
Closely correlated
-0.88%
NERV - DMRA
45%
Loosely correlated
-7.03%
INBX - DMRA
44%
Loosely correlated
-3.14%
RANI - DMRA
44%
Loosely correlated
-7.54%
VIVS - DMRA
38%
Loosely correlated
-10.80%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-3.14%
AXON - INBX
48%
Loosely correlated
-2.63%
NEUP - INBX
47%
Loosely correlated
-5.17%
BCAX - INBX
46%
Loosely correlated
-3.99%
DYN - INBX
39%
Loosely correlated
-5.45%
SNTI - INBX
39%
Loosely correlated
-6.49%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCAP66.001.38
+2.14%
First Capital
FITB53.90-0.50
-0.92%
Fifth Third Bancorp
QTWO72.95-1.19
-1.61%
Q2 Holdings
TUYA1.61-0.04
-2.42%
Tuya
JF0.93-0.09
-9.24%
J and Friends Holdings Limited